Detalles de la búsqueda
1.
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722.
J Clin Oncol
; 42(11): 1252-1264, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38252907
2.
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes.
Eur J Cancer
; 183: 174-187, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871487
3.
A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study.
J Gastrointest Cancer
; 43(4): 562-9, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22294255
Resultados
1 -
3
de 3
1
Próxima >
>>